Behaviour of some indicators of oxidative stress in postmenopausal and fertile women

Maturitas

Volumn 53, Issue 1, 2006, Pages 77-82

  Signorelli, Salvatore Santo ^a   Neri, Sergio ^b   Sciacchitano, Salvatore ^b   Di Pino, Luigi ^a   Costa, Maria Pia ^a   Marchese, Giuseppe ^a   Celotta, Gabriella ^a   Cassibba, Nunziata ^a   Pennisi, Giuseppe ^a   Caschetto, Sarina ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Menopause; Oxidative stress

Indexed keywords

GLUTATHIONE PEROXIDASE; LIPOPROTEIN; MALONALDEHYDE;

ADULT; ARTICLE; BEHAVIOR; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FERTILITY; HORMONE SUBSTITUTION; HUMAN; MENSTRUATION; OXIDATIVE STRESS; POSTMENOPAUSE;

ADULT; ALDEHYDES; ANALYSIS OF VARIANCE; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FERTILITY; GLUTATHIONE PEROXIDASE; HUMANS; LIPOPROTEINS, LDL; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE;

EID: 28444440271     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.03.001     Document Type: Article

References (36)

1. J. Whitman, D. Grebe, F.J. Kook, A. Hofman, and H.A. Valkenburg Increased risk of atherosclerosis in women after menopause BMJ 298 1989 642 644
2. E. Barrett-Connor Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture Circulation 95 1997 252 264
3. W.M. Van Baal, T. Kooistra, and C.D. Stehouwer Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomized, controlled studies in postmenopausal women Curr Med Chem 2000 499 517
4. V. Mijatovic, M.J. Van der Mooren, Stehouwer CDA, J.C. Netelenbos, and P. Kenemans Postmenopausal hormone replacement, risk estimation for coronary heart disease and cardiovascular protection Gynecol Endocrinol 13 1999 130 144
5. D.F. Archer Progestogens effects on coronary arteries: the need for definitive clinical trials Menopause 8 1 2001 1 2
6. B.W. Walsh, I. Schiff, and B. Rosner Effects of postmenopausal estrogen replacement on the concentration and metabolism of lipoproteins N Engl J Med 325 1991 196 204
7. M.J. Stampfer, and G.A. Colditz Estrogen replacement therapy and coronary heart disease: a quantitative assessment of epidemiologic evidence Prev Med 20 1991 47 63
8. T.L. Bush Preserving cardiovascular benefits of hormone replacement therapy J Reprod Med 45 2000 259 272
9. B.W. Walsh, I. Schiff, and B. Rosner Effects of postmenopausal estrogen replacement on the concentration and metabolism of lipoproteins N Engl J Med 325 1991 196 204
10. G. Berg, H. Halperin, N. Siseles, and R. Wikinski Very low-density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women Medicina 56 1996 479 486
11. F.M. Sacks, R. McPherson, and B.W. Walsh Effect of postmenopausal estrogen replacement therapy on plasma Lp(a) lipoprotein concentration Arch Intern Med 154 1994 1106 1110
12. F. Grudstein, and M.J. Stampfer Estrogen for women at varying risk of coronary disease Maturitas 30 1998 19 26
13. R. Ross The pathogenesis of atherosclerosis: an update N Engl J Med 314 1986 488 500
14. D. Stenberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witzum Beyond cholesterol N Engl J Med 320 1989 915 924
15. D. Stemberg Low-density lipoprotein-oxidation and its pathological significance J Biol Chem 272 1997 20963 20966
16. K. Yagi Assay for serum lipid peroxide level and its chemical significance K. Yagi Lipid peroxides in biology and medicine 1982 Academic Press NY 223 242
17. M.M. Bradfort A rapid and sensitive method for quantification of micrograms quantities of protein utilizing the principle of protein binding Anal Biochem 72 1976 248
18. H. Esterbauer, and Cheeseman KH Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal Methods Enzymol 18 1990 407
19. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70 1967 158
20. G. Watts, and B. Lewis Brunt J Effects on coronary artery disease of lipid-lowering diet or diet plus cholestyramine in the St. Thomas' Atherosclerosis Regression Study (STARS) Lancet 339 1992 563 569
21. J. Sheperd, S. Cobbe, and I. Ford Packard CJ Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 338 1995 1301 1307
22. Scandinavian Simvatstatin Survival Study Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
23. J. Jukema, A. Bruschke, and A.J. van Boven Effects of lipid lowering by pravastatin in progression and regression of coronary artery disease in symptomatic men with moderately elevated serum cholesterol levels: The Regress Growth Evaluation Statin Study (REGRESS) Circulation 91 1995 2528 2540
24. B. Pitt Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin Versus Revascularization Treatment investigators N Engl J Med 341 1999 7 76
25. The Long Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
26. A. Mugge, M. Riedel, and M. Bartan Endothelium independent relaxation of human coronary arteries by 17 beta estradiol in vitro Br J Pharmacol 104 1993 1033 1037
27. O. Yliorkala, B. Cacciatore, J. Paakari, M.J. Tikkanen, L. Viinikka, and J. Toivonen The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin1, prostacyclin, and thromboxane Fertil Steril 69 5 1998 883
28. Dantas Ap, R. Scivoletto, Z.B. Fortes, D. Nigro, and M.H. Carvalho Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats Hypertension 34 1999 914 919
29. S. Signorelli, S. Sciacchitano, L. Di Pino, M.P. Costa, G. Pennisi, and S. Caschetto Serum lipids and lipoproteins and carotid artery wall intra-media thickness in a population of menopausal women Menopause 6 3 1999 10 13
30. S. Signorelli, S. Sciacchitano, L. Di Pino, M.P. Costa, G. Pennisi, and S. Caschetto Effects of long-term hormone replacement therapy on arterial wall thickness, lipids, lipoproteins and fibrinogen and antithrombin III Gynecol Endocrinol 15 2001 1 6
31. S. Signorelli, S. Neri, and S. Sciacchitano Duration of menopause and behaviour of malondialdehyde, lipids, lipoproteins and carotid wall intima-media thickness Maturitas 39/1 2001 39 42
32. J. McManus, J. McEhney, I.S. Young, and W. Thompson The effect of various estrogens and progestogens on the susceptibility of low-density lipoprotein to oxidation in vitro Maturitas 25 1996 125 131
33. R. Rontu, T. Solakivi, K. Teisala, T. Lehtimaki, R. Punnonen, and H. Jokela Imapct of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation Free Radical Res 38 2 2004 129 137
34. G.T. Shwaery, J.A. Vita, and J.F. Keaney Antioxidant protection of LDL by physiological concentrations of 17β-estradiol: requirement for estradiol modification Circulation 95 1997 1378 1385
35. M. Lacort, A.M. Leal, M. Liza, C. Martin, R. Martinez, and M.B. Riuz-Larrea Protective effects of estrogens and cathechol estrogens against peroxidative membrane damage in vitro Lipids 30 1995 141 146
36. B.R. Bhavnani, A. Cecutti, A. Gerulath, A.C. Woolever, and M. Berco Comparison of the antioxidant effects of equine estrogens, red wine, Vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women Menopause 8 6 2001 408 419